Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study

Table 2

Characteristics of patients after the initiation of insulin pump therapy.

Variable	Measure
Time with insulin pump therapy (months)	24 (18-49)
Weight (kg)	64 (56-72)
BMI	24.8 (22.25-27.5)
HbA1c posterior to the initiation of IPT (%)	7.5 (6.9–8.1)
Insulin dose (IU)	37 (27.4-51.1)
Use of continuous glucose sensor (%)	80.3
Distribution of insulin use
Basal	51 (43-57)
Boluses	49 (43-57)
Units of basal insulin	4 (3-5)
Units of correction insulin	90 (67.4-96.6)
Overcorrection
Yes	7 (13.7)
Not	44 (86.2)
Coefficient of variability (%)
SD of glucose measures calculated by CGM (mg/dL)
Complications associated to the use of IPT
None	28 (55.5)
Irritation at the catheter insertion site	12 (23)
Infection at the catheter insertion site	6 (11.7)
Diabetic ketoacidosis	5 (9.8)

Reported as mean value (standard deviation). Values reported as absolute number, (percentage). Reported as median (interquartile range). BMI: body mass index; HbA1c: glycosylated hemoglobin; IPT: insulin pump therapy; IU: international units; SD: standard deviation.